angiotensin ii has been researched along with Peritoneal Carcinomatosis in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiao, Y; Lam, MMT; Lee, LTO; Poon, TCW; Sun, L; Wong, AST; Yu, S; Zhang, Q | 1 |
| Fujimura, T; Fujita, H; Fushida, S; Harada, S; Hirakawa, K; Kayahara, M; Kinami, S; Kinoshita, J; Ninomiya, I; Ohta, T; Yagi, Y; Yashiro, M | 1 |
| Ishikawa, T; Kamimura, T; Mizuno, K; Ohta, H; Seki, K; Togashi, T; Watanabe, K; Yoshida, T | 1 |
| Arai, K; Kitamura, M; Miyashita, K | 1 |
| Aoki, K; Baba, T; Hasuda, K; Kobayashi, H; Kuroiwa, T; Taniguchi, S | 1 |
5 other study(ies) available for angiotensin ii and Peritoneal Carcinomatosis
| Article | Year |
|---|---|
Angiotensin II promotes ovarian cancer spheroid formation and metastasis by upregulation of lipid desaturation and suppression of endoplasmic reticulum stress.
Topics: Angiotensin II; Animals; Carcinoma, Ovarian Epithelial; Cell Movement; Endoplasmic Reticulum Stress; ErbB Receptors; Female; Gene Expression Regulation, Neoplastic; Humans; Lipid Metabolism; Lipids; Mice; Neoplasm Metastasis; Peritoneal Neoplasms; Prognosis; Proteomics; Receptor, Angiotensin, Type 1; Spheroids, Cellular; Stearoyl-CoA Desaturase; Xenograft Model Antitumor Assays | 2019 |
Local angiotensin II-generation in human gastric cancer: correlation with tumor progression through the activation of ERK1/2, NF-kappaB and survivin.
Topics: Adenocarcinoma; Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Adult; Aged; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Benzimidazoles; Biphenyl Compounds; Blotting, Western; Carcinoma, Medullary; Case-Control Studies; Cell Proliferation; Disease Progression; Electrophoretic Mobility Shift Assay; Female; Gastric Mucosa; Humans; Immunoenzyme Techniques; Inhibitor of Apoptosis Proteins; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Microtubule-Associated Proteins; Middle Aged; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; NF-kappa B; Peritoneal Neoplasms; Receptor, Angiotensin, Type 1; Stomach; Stomach Neoplasms; Survival Rate; Survivin; Tetrazoles; Tumor Cells, Cultured | 2009 |
[Modified pharmacokinetic modulating chemotherapy for progressive gastric cancer accompanied by peritoneal dissemination].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Drug Combinations; Female; Fluorouracil; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Male; Methotrexate; Middle Aged; Peritoneal Neoplasms; Stomach Neoplasms; Survival Rate; Tegafur; Uracil | 2005 |
[Evaluation of the liver and peritoneal metastasis in the treatment of gastric carcinoma with intra-arterial injection in terms of survival period].
Topics: Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Fluorouracil; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Mitomycin; Mitomycins; Peritoneal Neoplasms; Prognosis; Stomach Neoplasms; Survival Rate | 1990 |
"Two-route chemotherapy" using cis-diamminedichloroplatinum(II) and its antidote, sodium thiosulfate, combined with angiotensin II is effective against peritoneally disseminated cancer in rats.
Topics: Angiotensin II; Animals; Antidotes; Blood Pressure; Carcinoma, Transitional Cell; Cisplatin; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Therapy, Combination; Female; Kidney; Neoplasm Transplantation; Peritoneal Neoplasms; Rats; Rats, Inbred Strains; Thiosulfates; Urinary Bladder Neoplasms | 1989 |